中华眼底病杂志
中華眼底病雜誌
중화안저병잡지
CHINESE JOURNAL OF OCULAR FUNDUS DISEASES
2009年
1期
8-10
,共3页
眼异物/并发症%眼异物/外科学%玻璃体切除术
眼異物/併髮癥%眼異物/外科學%玻璃體切除術
안이물/병발증%안이물/외과학%파리체절제술
Eye foreign bodies/complications%Eye foreign bodies/surgery%Vitrectomy
目的 观察铁锈症眼玻璃体视网膜手术治疗的疗效.方法 回顾分析玻璃体视网膜手术治疗眼后段磁性异物诱发眼铁锈症22例22只眼的临床资料.男性21例,女性1例;年龄6~54岁,平均年龄40岁.异物存留于眼内1个月~20年.手术前最佳矫正视力(BCVA)<0.01者15只眼,0.01~0.15者5只眼,0.1~0.2者2只眼.玻璃体腔异物18只眼,眼球壁异物4只眼.并发白内障18只眼.合并视网膜脱离3只眼.12只眼联合环扎、硅油填充,7只眼联合环扎、C3F8填充.18只眼联合白内障摘除术.2只眼联合小梁切除术.结果 22只眼内异物均手术一次成功摘除.手术后视力增加20只眼,占90.9%,不变2只眼,占9.1%.BCVA<0.1者7只眼,0.1~0.4者8只眼,0.5~1.0者7只眼.手术中并发症,视网膜裂孔并发局限性视网膜脱离2只眼;扩大巩膜切口,玻璃体腔积血2只眼.手术后并发症,并发白内障4只眼;黄斑下异物取出手术后3个月,硅油取出时再次发生视网膜脱离1只眼,再次硅油填充视网膜复位;C3F8填充后7 d继发视网膜脱离1只眼.再次硅油填充,手术后视网膜复位.随访结束时22只眼视网膜均在位.结论 铁锈症眼玻璃体视网膜手术治疗安全、有效,可避免铁离子进一步释放,改善患者视功能.
目的 觀察鐵鏽癥眼玻璃體視網膜手術治療的療效.方法 迴顧分析玻璃體視網膜手術治療眼後段磁性異物誘髮眼鐵鏽癥22例22隻眼的臨床資料.男性21例,女性1例;年齡6~54歲,平均年齡40歲.異物存留于眼內1箇月~20年.手術前最佳矯正視力(BCVA)<0.01者15隻眼,0.01~0.15者5隻眼,0.1~0.2者2隻眼.玻璃體腔異物18隻眼,眼毬壁異物4隻眼.併髮白內障18隻眼.閤併視網膜脫離3隻眼.12隻眼聯閤環扎、硅油填充,7隻眼聯閤環扎、C3F8填充.18隻眼聯閤白內障摘除術.2隻眼聯閤小樑切除術.結果 22隻眼內異物均手術一次成功摘除.手術後視力增加20隻眼,佔90.9%,不變2隻眼,佔9.1%.BCVA<0.1者7隻眼,0.1~0.4者8隻眼,0.5~1.0者7隻眼.手術中併髮癥,視網膜裂孔併髮跼限性視網膜脫離2隻眼;擴大鞏膜切口,玻璃體腔積血2隻眼.手術後併髮癥,併髮白內障4隻眼;黃斑下異物取齣手術後3箇月,硅油取齣時再次髮生視網膜脫離1隻眼,再次硅油填充視網膜複位;C3F8填充後7 d繼髮視網膜脫離1隻眼.再次硅油填充,手術後視網膜複位.隨訪結束時22隻眼視網膜均在位.結論 鐵鏽癥眼玻璃體視網膜手術治療安全、有效,可避免鐵離子進一步釋放,改善患者視功能.
목적 관찰철수증안파리체시망막수술치료적료효.방법 회고분석파리체시망막수술치료안후단자성이물유발안철수증22례22지안적림상자료.남성21례,녀성1례;년령6~54세,평균년령40세.이물존류우안내1개월~20년.수술전최가교정시력(BCVA)<0.01자15지안,0.01~0.15자5지안,0.1~0.2자2지안.파리체강이물18지안,안구벽이물4지안.병발백내장18지안.합병시망막탈리3지안.12지안연합배찰、규유전충,7지안연합배찰、C3F8전충.18지안연합백내장적제술.2지안연합소량절제술.결과 22지안내이물균수술일차성공적제.수술후시력증가20지안,점90.9%,불변2지안,점9.1%.BCVA<0.1자7지안,0.1~0.4자8지안,0.5~1.0자7지안.수술중병발증,시망막렬공병발국한성시망막탈리2지안;확대공막절구,파리체강적혈2지안.수술후병발증,병발백내장4지안;황반하이물취출수술후3개월,규유취출시재차발생시망막탈리1지안,재차규유전충시망막복위;C3F8전충후7 d계발시망막탈리1지안.재차규유전충,수술후시망막복위.수방결속시22지안시망막균재위.결론 철수증안파리체시망막수술치료안전、유효,가피면철리자진일보석방,개선환자시공능.
Objective To evaluate the therapeutic effect of vitreo-retinal surgery on oclular siderosis. Methods The clinical data of 22 patinets (22 eyes) with ocular siderosis due to the magnetic foreign body at intraocular postsegment were retrospectively analyzed. The patients aged from 6 to 54 years (average 40 years), including 21 males and 1 femal. The duration of the magnetic foreign body remained in the eye lasted for 1 month to 20 years. The preoperative best corrected visual acuity (BCVA) was <0.01 in 15 eyes, 0. 01-0. 15 in 5 eyes and 0.1-0.2 in 2 eyes. There was Intra-vitreous foreign body in 18 eyes and ocular wall embedded foreign body in 4 eyes; intraocular foreign body (IOFB) combined with cataract in 18 eyes; combined with retinal detachment in 3 eyes; scleral buckling combined with silicon oil filled in 12 eyes and C3F8 filled in 7 eyes. Cataract extraction was performed in 12 eyes, and 2 eyes underwent filtrating surgery. Results The IOFB was successfully removed by one-off surgery in 22 eyes. BCVA increased in 20 eyes (90.9%) and kept unchanged in 2 eyes (9. 1%), including<0.1 in 7 eyes, 0. 1-0.4 in 8 eyes, and 0.5-1.0 in 7 eyes. Operative complications involved retinal holes with retinal detachment in 2 eyes and vitreous haemorrhage secondary to enlarge sclera incision in 2 eyes. Postoperative complications included secondary cataract in 4 eyes, retinal detachment due to silicon oil removal 3 months after submacular removal of foreign body in 1 eye, and retinal detachment 7 days after C3F8 filling in 1 eye; the latter two eyes had reattached retina after another silicon oil filling. At the end of the follow-up period, retina reattached in 22 eyes. Conclusion Advanced modern vireo-retinal operation is ffective on oclular siderosis, which can avoid the release of Fe+ and improve the patients' visual function.